Literature DB >> 20358280

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation.

Jae Eun Ahn1, Jonathan L French.   

Abstract

Literature data are often reported as multiple (longitudinal) mean outcomes observed in several groups of patients within a study. Observations within a study are correlated because the patients come from a common population, and the mean observations over time within a treatment arm are correlated because they are based on the same set of patients. As a result, model-based meta-analysis may require more than two levels of random effects to correctly characterize this correlation structure. Using simulation, we explored and evaluated ways to implement multi-level random effects in NONMEM. Simulation models that were linear and non-linear in the random effects were investigated. We compared estimation models that included study and/or treatment arm-level random effects, with and without residual correlation. With all estimation strategies, the fixed random effects parameters were accurately estimated. With regard to correctly characterizing the variability, models that accounted for correlation within a study and treatment arm over time were the best in some situations, while models that accounted for study-level correlation only were better in others. Models that included only treatment arm-level random effects were not superior in any scenario.

Entities:  

Mesh:

Year:  2010        PMID: 20358280     DOI: 10.1007/s10928-010-9152-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  22 in total

1.  Multivariate meta-analysis.

Authors:  In-Sun Nam; Kerrie Mengersen; Paul Garthwaite
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

2.  Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

Authors:  Pascal Piedbois; Marc Buyse
Journal:  J Clin Oncol       Date:  2004-08-23       Impact factor: 44.544

Review 3.  Ecologic studies revisited.

Authors:  Jonathan Wakefield
Journal:  Annu Rev Public Health       Date:  2008       Impact factor: 21.981

4.  Meta-analysis of longitudinal studies.

Authors:  K Jack Ishak; Robert W Platt; Lawrence Joseph; James A Hanley; J Jaime Caro
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

5.  Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.

Authors:  Ashley P Jones; Richard D Riley; Paula R Williamson; Anne Whitehead
Journal:  Clin Trials       Date:  2009-02       Impact factor: 2.486

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 7.  Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis.

Authors:  D J Cook; D L Sackett; W O Spitzer
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

8.  The importance of modeling interoccasion variability in population pharmacokinetic analyses.

Authors:  M O Karlsson; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1993-12

9.  Disease progression meta-analysis model in Alzheimer's disease.

Authors:  Kaori Ito; Sima Ahadieh; Brian Corrigan; Jonathan French; Terence Fullerton; Thomas Tensfeldt
Journal:  Alzheimers Dement       Date:  2009-07-09       Impact factor: 21.566

10.  Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models.

Authors:  Ian R White; Nicky J Welton; Angela M Wood; A E Ades; Julian P T Higgins
Journal:  Stat Med       Date:  2008-02-28       Impact factor: 2.373

View more
  29 in total

1.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

2.  Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis.

Authors:  Hiroyuki Inoue; Yoko Tamaki; Yushi Kashihara; Shota Muraki; Makoto Kakara; Takeshi Hirota; Ichiro Ieiri
Journal:  Br J Clin Pharmacol       Date:  2018-12-06       Impact factor: 4.335

3.  Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis.

Authors:  Holly Kimko; Ekaterina Gibiansky; Leonid Gibiansky; H Lynn Starr; Joris Berwaerts; Joseph Massarella; Frank Wiegand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-22       Impact factor: 2.745

Review 4.  Integration of PKPD relationships into benefit-risk analysis.

Authors:  Francesco Bellanti; Rob C van Wijk; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-07-29       Impact factor: 4.335

5.  Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-05-02       Impact factor: 2.745

6.  Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer.

Authors:  Wenjun Chen; Liang Li; Shuangmin Ji; Xuyang Song; Wei Lu; Tianyan Zhou
Journal:  Eur J Clin Pharmacol       Date:  2020-01-10       Impact factor: 2.953

7.  Optimal sampling scheme for estimation of intraocular pressure diurnal curves in glaucoma trials.

Authors:  Chandrasekar Durairaj
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

8.  Comparative efficacy of nonhormonal drugs on menopausal hot flashes.

Authors:  Lujin Li; Ling Xu; Junyi Wu; Lidan Dong; Shuiyu Zhao; Qingshan Zheng
Journal:  Eur J Clin Pharmacol       Date:  2016-07-24       Impact factor: 2.953

9.  Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.

Authors:  J Wu; L Xu; Y Lv; L Dong; Q Zheng; L Li
Journal:  Osteoporos Int       Date:  2017-03-23       Impact factor: 4.507

10.  A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain.

Authors:  François Mercier; Laurent Claret; Klaas Prins; René Bruno
Journal:  Pain Ther       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.